Diazepam Abuse in Pregnant Women on Methadone Maintenance

Abstract

The authors found that the course and treatment of narcotic withdrawal in two neonates was complicated by prenatal exposure to high doses of diazepam, or Valium (Roche Laboratories, Nutley, NJ). Both of the mothers were on methadone maintenance for narcotic dependency prior to the diagnosis of pregnancy. The authors documented maternal intake of diazepam in the range of 40-60 mg/day for a duration of 4-27 weeks prior to delivery. Both infants initially responded well to medical therapy for narcotic withdrawal, but at 7-14 days of age, withdrawal symptoms intensified, requiring an increase in the dosages of Paregoric (UDL Laboratories, Rockford, IL) and opium tincture in both infants and the addition of phenobarbital therapy in one infant. Both infants continued on medical therapy until they reached 1 month of age.

Diazepam use by pregnant women can be associated with a later presentation of withdrawal symptoms in the neonate than that induced by the use of other drugs. Close follow-up during the first month of life is warranted for infants exposed to diazepam prenatally.

Get full access to this article

View all access options for this article.

References

Ostrea E. , Chavez C. , Strauss M. A study of factors that influence the severity of neonatal narcotic withdrawal . J Pediatr 1976;88:642-5.

Chasnoff I. Newborn infants with drug withdrawal symptoms. Pediatrics in Review 1988;9:273-7.

Finnegan L. A scoring system for evaluation and treatment of neonatal abstinence syndrome: a new clinical and research tool. In: Morselli P , Garattini S , Sereni F , eds. Basic and therapeutic aspects of perinatal pharmacology. New York: Raven Press , 1975:139-53.

Srinivasan G. Infants of drug-dependent mothers. In: Yeh T , ed. Drug therapy in the neonate and small infant. Chicago: Year Book Medical Pub, 1985:30-9.

Blinick G. , Wallach R. , Jerez E. , et al. Drug addiction in pregnancy and the neonate. Am J Obstet Gynecol 1976;125:135-42.

Finnegan L. , Michael H. , Leifer B. , et al. An evaluation of neonatal abstinence treatment modalities. In: Harris L, ed. Problems of drug dependence, 1983. Proceedings of the 45th annual scientific meeting. Rockville, MD: U.S. Department of Health and Human Services, 1984:282-8. (National Institute for Drug Abuse Research Monograph Series; vol 49).

Finnegan L. , Ehrlich S. Maternal drug abuse during pregnancy and pharmacotherapy for neonatal abstinence syndrome. Pediatr Res 1987;21:369.

Rementeria J. , Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 1977;90:123-6.

Kandall S. , Albin S. , Gartner L. , et al. The narcotic-dependent mother: fetal and neonatal consequences . Early Hum Dev 1977;1:159-69.

10.

Connaughton J. , Reeser D. , Schut J. , et al. Perinatal addiction: outcome and management. Am J Obstet and Gynecol 1977;129:679-85.

11.

Finnegan L, ed. Drug dependence in pregnancy: clinical management of mother and child. Washington, DC: National Institute for Drug Abuse Service , 1979:38. DHEW publication no. (ADM) 79-678. (Research Monograph Series).

12.

Kreek M. Drug interactions with methadone in humans. Washington, DC: National Institute for Drug Abuse, 1986:193-225. DHEW Publication No. (Research Monograph Series; vol 68).

13.

Kreek M. Methadone disposition during the perinatal periods in humans. Pharmacol Biochem Behav [Suppl] 1979;11:7-13.

14.

Kreek M. , Schecter A. , Gutjahr C. , et al. Analyses of methadone and other drugs in maternal and neonatal body fluids: use in evaluation of symptoms in a neonate of mother maintained on methadone. Am J Drug Alcohol Abuse 1974 ;1:409-19.

15.

Pond S. , Kreek M. , Tong T. , et al. Changes in methadone pharmacokinetics during pregnancy. J Pharmacol Exp Ther 1985;234:1-6.

16.

Smith D, ed. Abuse of benzodiazepines: problems and solutions. Addictions Alert 1989 ;2:37-8.